These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28297143)

  • 1. Cushing's Syndrome Induced by High-Potency Topical Corticosteroids in Two Children with Palmoplantar Psoriasis Taking Acitretin.
    Mahé E
    Pediatr Dermatol; 2017 Mar; 34(2):219-220. PubMed ID: 28297143
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse.
    Negrini S; Murdaca G; Ferone D; Borro M
    Therapie; 2019 Oct; 74(5):547-549. PubMed ID: 31023618
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome induced by enhanced systemic absorption of topical corticosteroids when co-administered with hand sanitiser in a patient with COVID-19-induced chronic plaque psoriasis.
    Truong K; Thai KE
    Skin Res Technol; 2023 Jun; 29(6):e13375. PubMed ID: 37357655
    [No Abstract]   [Full Text] [Related]  

  • 4. Cushing's syndrome induced by high-potency topical corticosteroids.
    Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
    Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic Cushing's syndrome due to topical steroid abuse in a child with Psoriasis presenting as septicaemia.
    Sachdeva S; Arora P; Kulhari A; Sardana K
    Dermatol Ther; 2020 Jul; 33(4):e13514. PubMed ID: 32374062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasol, Acitretin, and Cushing's Syndrome.
    Di Lernia V; Neri I
    Pediatr Dermatol; 2017 Mar; 34(2):221. PubMed ID: 28297151
    [No Abstract]   [Full Text] [Related]  

  • 7. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
    Raposo I; Torres T
    Am J Clin Dermatol; 2016 Aug; 17(4):349-58. PubMed ID: 27113059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iatrogenic Cushing's syndrome in a infant due to prolonged use of topical corticosteroids. Case report].
    Hansen S J; Lacourt R P
    Rev Chil Pediatr; 2018 Jun; 89(3):368-372. PubMed ID: 29999143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis: state of the art 2013.
    de la Brassinne M; Nikkels A
    Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal.
    Durmazlar SP; Oktay B; Eren C; Eskioglu F
    Eur J Dermatol; 2009; 19(2):169-70. PubMed ID: 19106046
    [No Abstract]   [Full Text] [Related]  

  • 14. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cushing syndrome following external glucocorticoid administration in psoriasis].
    Dhein S
    Z Hautkr; 1986 Feb; 61(3):161-6. PubMed ID: 3953135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation.
    Malozowski S; Purucker M; Worobec A
    BMJ; 1999 May; 318(7194):1355. PubMed ID: 10383213
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of pediatric psoriasis with acitretin: A review.
    Subedi S; Yu Q; Chen Z; Shi Y
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29094450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Of Iatrogenic Cushing's Syndrome By Topical Triamcinolone.
    Zil-E-Ali A; Janjua OH; Latif A; Aadil M
    J Ayub Med Coll Abbottabad; 2018; 30(1):121-123. PubMed ID: 29504347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
    Rim JH; Park JY; Choe YB; Youn JI
    Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picture of the month. Cushing's syndrome due to topical corticosteroids.
    Gemme G; Ruffa G; Bonioli E; Lagorio V; Feingold M
    Am J Dis Child; 1984 Oct; 138(10):987-8. PubMed ID: 6475861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.